# OnCo record paper-eichenauer-nlphl-ghsg-hd7-hd15-long-term-jco-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-eichenauer-nlphl-ghsg-hd7-hd15-long-term-jco-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-eichenauer-nlphl-ghsg-hd7-hd15-long-term-jco-2020" ;
  schema:name "Long-term follow-up of nodular lymphocyte-predominant Hodgkin lymphoma treated in the GHSG HD7 to HD15 trials"@en ;
  schema:description "The largest long-term series of nodular lymphocyte-predominant Hodgkin lymphoma found that three-quarters of patients were still free of the disease ten years after standard Hodgkin lymphoma treatment and more than nine in ten were alive, but most of the deaths came from second cancers and treatment effects rather than from the lymphoma itself."@en ;
  schema:url <https://onco.cc/key-papers/paper-eichenauer-nlphl-ghsg-hd7-hd15-long-term-jco-2020/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.19.00986>, <https://pubmed.ncbi.nlm.nih.gov/31626571/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.19.00986> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Eichenauer DA, Plütschow A, Fuchs M, et al." ;
  onco:cancers <https://onco.cc/cancers/nodular-lymphocyte-predominant-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vinblastine/>, <https://onco.cc/drugs/dacarbazine/> ;
  onco:institutions <https://onco.cc/institutions/ghsg/> ;
  onco:journals <https://onco.cc/journals/jco/> .